Physician profile
Alan Epstein
NPI 1831157908
$35,500.70
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $3,830 · 2021: $8,142 · 2022: $9,431 · 2023: $120 · 2024: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $224.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $28,456.17 | 2019-2024 | |
| Abbvie INC. | $1,855.51 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,099.01 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $1,060.40 | 2019-2022 | |
| Janssen Biotech, INC. | $869.97 | 2019-2022 | |
| Pfizer INC. | $627.45 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $595.66 | 2020-2023 | |
| Redhill Biopharma INC. | $179.19 | 2020-2022 | |
| Celgene Corporation | $149.55 | 2021-2022 | |
| Allergan, INC. | $135.75 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $125.64 | 2019-2022 | |
| Braintree Laboratories, INC. | $112.28 | 2020-2021 | |
| Boston Scientific Corporation | $69.63 | 2019 | |
| Merck Sharp & Dohme LLC | $49.40 | 2019-2020 | |
| Intercept Pharmaceuticals, INC. | $39.15 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alfasigma USA, INC. | $36.38 | 2020 | |
| Ferring Pharmaceuticals INC. | $14.74 | 2022 | |
| Qol Medical, LLC | $13.17 | 2021 | |
| Olympus America INC. | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Epstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.